Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02822170 · ClinicalTrials.gov registry record · NA

A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT02822170 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02822170, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The purpose of this small pilot study is to refine a combined intervention of IV amino acids and cycle ergometry in critically ill patients, and to gather preliminary data, before proceeding with a larger multi-center RCT. A total of 10 patients will receive the combined intervention.

Interventions

  • OTHER IV amino acids and in-bed cycle ergometry

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-06
Est. Completion 2017-08
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT02822170

The ClinicalTrials.gov registry entry for NCT02822170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which IV amino acids and in-bed cycle ergometry is the first listed.

NCT02822170 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02822170 about?

NCT02822170 is a clinical study titled "A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU". The purpose of this small pilot study is to refine a combined intervention of IV amino acids and cycle ergometry in critically ill patients, and to gather preliminary data, before proceeding with a larger multi-center RCT. A total of 10 patients will receive the combined intervention.

What is the current status of trial NCT02822170?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-06. Estimated completion is 2017-08.

What interventions are being tested in trial NCT02822170?

The interventions under investigation include: IV amino acids and in-bed cycle ergometry (OTHER).

Who is sponsoring clinical trial NCT02822170?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.